Health Canada — Medical Devices · Canada · 2015-10-22 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: An anomaly was identified with the ARIA for Radiation Oncology software with a clinical assessment license. Admin instructions may not print on drug order prescriptions or be transmitted with electronic prescribing (e-Rx). When the user changes the prescription "type" field after inputting admin instructions in the text box, the admin instructions portion of the prescription will not be saved to the database. An e-Rx transmitted to the pharmacy will not contain the intended admin instructions. The printed prescription will also not contain the intended admin instructions. This anomaly only occurs for sites that have a clinical assessment license for the aria radiation oncology software / licence set. ARIA users who do not have a clinical assessment license will not be affected.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.